Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal Dexmedetomidine with Bupivacaine for Analgesia after Laparoscopic Cholecystectomy
NCT06560892Completed
- Sponsor
- RESnTEC (Research and Technology) Ltd
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by RESnTEC (Research and Technology) Ltd. Primary endpoint: Duration of analgesia at 24 hours. Started Jan 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06560892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06560892.